Improvement in Patient-Reported Outcomes After Rituximab in Rheumatoid Arthritis Patients: An Open-Label Assessment of 175 Patients

Joint Bone Spine - France
doi 10.1016/j.jbspin.2015.02.007
Full Text
Abstract

Available in full text

Categories
Rheumatology
Date
Authors
Publisher

Elsevier BV

Related search

Influence of Rituximab on Markers of Bone Remodeling in Patients With Rheumatoid Arthritis: A Prospective Open-Label Pilot Study

Rheumatology International
RheumatologyAllergyImmunology
2010English

Rituximab Therapy in Greek Patients With Rheumatoid Arthritis

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Factors Correlated With Improvement of Endothelial Dysfunction During Rituximab Therapy in Patients With Rheumatoid Arthritis

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2013English

Impact of Tocilizumab Monotherapy on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis From Two Randomised Controlled Trials

RMD Open
RheumatologyAllergyImmunology
2017English

FRI0224 Rituximab Selectively Reduces Igg4 Levels in Rheumatoid Arthritis Patients

2017English

Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials

Journal of Rheumatology
RheumatologyAllergyImmunology
2010English

PATIENT-REPORTED OUTCOMES (PROs) IN WALDENSTRÖM MACROGLOBULINEMIA (WM) PATIENTS TREATED WITH IBRUTINIB-RITUXIMAB IN THE INNOVATE STUDY

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Safety of Rituximab in Rheumatoid Arthritis

Reumatismo
Rheumatology
2011English

Remission in Rheumatoid Arthritis: Benefit Over Low Disease Activity in Patient-Reported Outcomes and Costs

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy